Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy.

Eto M, Horita K, Morikawa A, Nakata H, Okada M, Saito M, Nomura M, Abiko A, Iwashima Y, Ikoda A, et al.

Clin Genet. 1995 Dec;48(6):288-92.

PMID:
8835322
2.

Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan.

Hsieh MC, Lin SR, Yang YC, Chen HC, Lin JN, Shin SJ.

J Nephrol. 2002 Jul-Aug;15(4):368-73.

PMID:
12243365
3.

Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.

Kimura H, Suzuki Y, Gejyo F, Karasawa R, Miyazaki R, Suzuki S, Arakawa M.

Am J Kidney Dis. 1998 Apr;31(4):666-73.

PMID:
9531184
4.

Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus.

Horita K, Eto M, Makino I.

Atherosclerosis. 1994 Jun;107(2):203-11.

PMID:
7980694
6.

[Insulin receptor substrate-1 and glucose transporter gene polymorphisms in noninsulin-dependent diabetes mellitus].

Liu Z, Guan T, Chen Z.

Zhonghua Yi Xue Za Zhi. 1998 Sep;78(9):662-5. Chinese.

PMID:
11038788
7.

Apolipoprotein E polymorphism in 385 patients on renal replacement therapy in Sweden.

Roussos L, Ekström U, Ehle PN, Oqvist B, Floren CH.

Scand J Urol Nephrol. 2004;38(6):504-10.

PMID:
15841787
8.
9.

Apolipoprotein E polymorphism and renal disease.

Oda H, Yorioka N, Ueda C, Kushihata S, Yamakido M.

Kidney Int Suppl. 1999 Jul;71:S25-7.

PMID:
10412731
10.

The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy.

Erdogan M, Eroglu Z, Biray C, Karadeniz M, Cetinkalp S, Kosova B, Gunduz C, Topcuoglu N, Ozgen G, Yilmaz C.

J Endocrinol Invest. 2009 Mar;32(3):219-22.

PMID:
19542737
11.

Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients.

Werle E, Fiehn W, Hasslacher C.

Diabetes Care. 1998 Jun;21(6):994-8.

PMID:
9614620
12.

[The relationship of Apo E2 and renal insufficiency lipid levels in NIDDM].

Xiang G, Xia B, He Y.

Zhonghua Yi Xue Za Zhi. 1999 May;79(5):339-41. Chinese.

PMID:
11715472
13.

Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients.

Leiva E, Mujica V, Elematore I, Orrego R, Díaz G, Prieto M, Arredondo M.

Diabetes Res Clin Pract. 2007 Nov;78(2):196-201. Epub 2007 May 3.

PMID:
17481771
14.

Apo E gene polymorphism on development of diabetic nephropathy.

Ilhan N, Kahraman N, Seçkin D, Ilhan N, Colak R.

Cell Biochem Funct. 2007 Sep-Oct;25(5):527-32.

PMID:
16933203
16.

[Apolipoprotein E epsilon 2 allele and diabetic nephropathy].

Eto M, Saito M, Kaku K.

Nihon Rinsho. 2001 Mar;59 Suppl 3:807-11. Review. Japanese. No abstract available.

PMID:
11347178
17.

Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients.

Eto M, Saito M, Okada M, Kume Y, Kawasaki F, Matsuda M, Yoneda M, Matsuki M, Takigami S, Kaku K.

Am J Kidney Dis. 2002 Aug;40(2):243-51.

PMID:
12148096
18.

APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study.

Araki S, Koya D, Makiishi T, Sugimoto T, Isono M, Kikkawa R, Kashiwagi A, Haneda M.

Diabetes Care. 2003 Aug;26(8):2416-20.

PMID:
12882872
19.

Supplemental Content

Support Center